Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
U.S. Bancorp closed the sale of 1,000,000 depositary shares, each representing a 1/25th interest in its new Series P Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock. The company filed a Certificate of Designations to establish the rights and preferences of the new preferred stock, which has a liquidation preference of $25,000 per share.
SunPower Inc. filed unaudited pro forma combined financial statements related to its previously completed acquisitions of Ambia Energy, LLC and Sunder Energy LLC. The filing provides updated financial data for the fiscal year ended December 28, 2025, to reflect these transactions as if they had occurred at the beginning of that period for future registration statement purposes.
Arch Capital Group M&A Deal with Premier Dealer Holding Corp.
Arch Insurance North America, a subsidiary of Arch Capital Group Ltd., has entered into a definitive agreement to acquire Premier Dealer Holding Corp. (PDS), a provider of automotive finance and insurance products. The acquisition aims to combine Arch's specialty insurance expertise with PDS's administration capabilities and technology infrastructure, with the deal expected to close by the end of 2026.
Bridger Aerospace Group Holdings Nasdaq/NYSE Compliance Notice
Bridger Aerospace Group Holdings received a deficiency notice from Nasdaq on October 28, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. Management is monitoring the situation and may consider options such as a reverse stock split to resolve the deficiency.
Silicon Valley Acquisition M&A Deal with EigenQ, Inc.
Silicon Valley Acquisition Corp. (SVAQ) provided a status update on its pending merger with EigenQ, Inc., a quantum security company. The update includes the filing of an investor presentation and transcript from an Analyst/Investor Day held on October 27, 2026, as the companies work toward closing the business combination.
Edible Garden AG Signs $6.33M M&A Deal with Iowa Shrimp Holdings, LLC
Edible Garden AG Incorporated completed the acquisition of a manufacturing facility in Hamilton County, Iowa, from Iowa Shrimp Holdings, LLC for an aggregate purchase price of $6.325 million. The consideration consisted of $2.5 million in Series B Preferred Stock and a $3.825 million secured promissory note issued to Streeterville Capital, LLC at the seller's direction. The acquired property will be developed as the Company’s Prairie Hills ready-to-drink manufacturing facility.
Pro-Dex subsidiary Advanced Precision Machining (APM) entered into a new lease for a 5,800 square foot industrial unit in Costa Mesa, California, and renewed existing leases for its current manufacturing and warehouse space through September 2030. The new facility more than doubles APM's existing 2,500 square foot footprint, supporting expanded manufacturing and office operations.
Parabolic Technologies received a delisting determination from Nasdaq after failing to maintain a minimum bid price of $1.00 for 30 consecutive business days. Because the company has already effected cumulative reverse stock splits exceeding a 1-for-250 ratio in the past two years, it is ineligible for a standard 180-day compliance period and faces immediate delisting unless it successfully appeals to a Nasdaq Hearings Panel.
Change Agents Corporation held a special meeting where stockholders approved several proposals related to equity financing, including the potential issuance of shares under an Equity Purchase Agreement with Hudson Global Ventures, LLC. Stockholders also approved the issuance of shares upon the conversion of promissory notes held by Vanquish Funding Group and an amendment to increase authorized common stock from 100 million to 125 million shares. These approvals were primarily sought to comply with Nasdaq Listing Rule 5635(d) regarding the issuance of 20% or more of outstanding shares.
Peoples Bancorp M&A Deal with Citizens National Corporation
Peoples Bancorp Inc. (PEBO) completed its acquisition of Citizens National Corporation and its subsidiary, Citizens Bank of Kentucky, effective October 30, 2026. Under the merger terms, Citizens shareholders received 2.10 shares of Peoples common stock plus $8.00 in cash for each share of Citizens common stock. The deal adds approximately $646 million in total assets and 12 branches to Peoples' Kentucky franchise.
Counterparty
Citizens National Corporation
“We are delighted to complete this combination with Citizens, which strengthens our Kentucky franchise and expands our reach into Eastern Kentucky. We are thankful for the hard work and dedication of the employees of Citizens and Peoples in completing this transaction. We look forward to welcoming Citizens’ shareholders and employees to become part of the Peoples team, and we are excited to introduce our array of products, services, and additional locations to clients in the communities served by Citizens.”
Tyler Wilcox, President and Chief Executive Officer of Peoples
Actuate Therapeutics received a deficiency notice from Nasdaq because its common stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. This notice follows a separate July 2026 warning regarding the company's failure to meet the minimum market value of listed securities requirement.
Neumora Therapeutics received a deficiency notice from Nasdaq for failing to maintain the $1.00 minimum bid price requirement for its common stock. The company has 180 calendar days, until April 26, 2027, to regain compliance by having its stock close at $1.00 or higher for at least ten consecutive business days.
Prologis, Inc. and its operating partnership entered into a new Equity Distribution Agreement to establish an 'at-the-market' (ATM) equity offering program. The program allows the company to issue and sell shares of common stock having an aggregate offering price of up to $5.0 billion from time to time. This agreement replaces and supersedes the company's existing ATM program.
Focus Universal Signs $17.7M M&A Deal with Jamison Services
Focus Universal Inc. completed the acquisition of a Class A office and commercial property located at 901 Corporate Center Drive in Monterey Park, California for $17.7 million. The property is 99.2% occupied by 16 tenants and will serve as the company's new corporate headquarters while generating approximately $3.1 million in annual rental income.
Value
$17.7M
Counterparty
Jamison Services
“We are very happy with our building purchase of $17.7 million, which was discounted further from the $17.7 million purchase price by over $419,000 due to rent prorations, security deposits, and other such reconciliation amounts. The building will serve as corporate headquarters, holding a very high capitalization rate for Los Angeles County of over 10%.”
Irving Kau, Chief Financial Officer
“From a financial perspective, we also believe there is significant value here as the building has a Los Angeles County Assessor assessed aggregate value of $28.3 million in 2026, over $10 million above our purchase price, despite the two valuation numbers being unrelated.”
Leader's Advantage Acquisition Capital Raise of $6.5M
Leader’s Advantage Acquisition Corp. closed the sale of an additional 650,000 units at $10.00 per unit following the partial exercise of the underwriters' over-allotment option. This transaction generated $6.5 million in additional gross proceeds, bringing the total IPO proceeds to $156.5 million. The company is a SPAC focused on identifying a healthcare-sector business combination.
ADM Tronics entered into a securities purchase agreement for a private placement targeting up to $5.4 million, completing two initial closings for aggregate gross proceeds of $1.55 million. The offering involves common stock at $0.10 per share and accompanying warrants, with proceeds intended for working capital and expansion into new deep technology areas. The transaction also includes a significant board reconstitution, appointing former Siemens CEO Klaus Kleinfeld as Chairman.
Texas Community Bancshares Signs $9.5M M&A Deal with The Banc of San Jacinto County Bancshares, Inc.
Texas Community Bancshares (TCBS) has entered into a definitive agreement to acquire The Banc of San Jacinto County Bancshares (SJCB) for $9.5 million in cash. The transaction includes SJCB's subsidiary, The Bank of San Jacinto County, which will be merged into TCBS's Broadstreet Bank. The deal is expected to close in the first quarter of 2027, subject to regulatory and SJCB shareholder approval.
BRB Foods Inc. entered into a definitive agreement to acquire 100% of PMZ Alimentos S.A., a Brazilian rice processor and packager, from a group of five contributors. In exchange for all PMZ shares, BRB will issue 2,800,000 shares of its common stock to the sellers, while CEO Paulo Roberto Bonifácio will surrender an equal number of his own shares to prevent dilution to other stockholders. The acquisition is scheduled to close immediately prior to and conditioned upon the closing of BRB's initial public offering on the NYSE American.
Brookfield Private Equity Fund Capital Raise of $6.2M
Brookfield Private Equity Fund LP sold unregistered limited partnership units for aggregate consideration of approximately $6.2 million on October 1, 2026. The sale was part of a continuous private offering that has raised approximately $420.6 million for the broader BPE Program since November 2025.
Hashdex Nasdaq CME Crypto Index ETF entered into an Authorized Participant Agreement with Jane Street Capital, LLC. The agreement establishes the procedures for Jane Street to create and redeem baskets of the ETF's common shares, facilitating the fund's ongoing capital issuance and liquidity.
Pelthos Therapeutics M&A Deal with Castle Creek Biosciences, Inc.
Pelthos Therapeutics has entered into a definitive agreement to acquire Castle Creek Biosciences in a merger transaction. Castle Creek stockholders will receive 5.2 million shares of Pelthos common stock plus potential milestone payments totaling up to $300 million tied to the clinical and commercial success of the D-Fi gene therapy franchise. The deal combines Pelthos' commercial dermatology infrastructure with Castle Creek's late-stage cell and gene therapy platform for rare skin diseases.
OpenWorld, Inc. entered into a securities purchase agreement for a $3.5 million registered direct offering with a single institutional investor. The company is selling 2,517,985 shares of common stock at a combined price of $1.39 per share, including accompanying Series A and Series B warrants. Proceeds are intended for real-world asset growth initiatives and general corporate purposes.
TerraVolt Holdings entered into option agreements to acquire 1,077 acres in Cassia County, Idaho, for the development of a 240 MW gas-powered digital infrastructure campus. The company paid a $150,000 option fee for the site, which is designed to operate behind-the-meter to avoid grid interconnection delays. The total purchase price for the land is approximately $32.31 million ($30,000 per acre), payable in a mix of cash and a convertible secured promissory note.
Pluri Inc. entered into a partnership agreement with ZEO ScientifiX to grant ZEO an exclusive license to manufacture and commercialize Pluri's regenerative medicine portfolio in the United States. In exchange, Pluri will receive a 50% equity stake in ZEO and the right to designate four out of seven board members, while ZEO will receive approximately 9% of Pluri's outstanding common shares.
Zeo ScientifiX entered into a definitive strategic agreement with Pluri Inc. to expand U.S. manufacturing and commercialization of regenerative medicine products. As part of the license-for-equity transaction, Pluri will grant ZEO an exclusive license to its proprietary 3D cell expansion platform in exchange for a 41% equity stake in ZEO and a share swap involving 4% of each company's outstanding stock.
Organon & M&A Deal with Sun Pharmaceutical Industries Limited
Organon & Co. provided a status update on its pending merger with Sun Pharmaceutical Industries Limited, noting that it has suspended customary earnings calls and press releases due to the transaction. The company furnished supplemental non-GAAP financial metrics for the third quarter of 2026 in lieu of a formal earnings release while the merger remains active.
Azenta acquired SynPlexity Inc., a synthetic biology company specializing in high-throughput gene libraries, and entered into an exclusive licensing and supply agreement with Elegen Corp. for its cell-free DNA manufacturing technology. The combined strategic investments involve an expected capital deployment ranging from $32 million to $71 million to expand Azenta's GENEWIZ gene synthesis capabilities and regional production capacity.
Game Your Game Inc. received a deficiency notice from Nasdaq on October 27, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, until April 26, 2027, to regain compliance by maintaining a $1.00 closing bid price for at least 10 consecutive business days. Separately, the company appointed Veronica V. Montenegro as an independent director and chairperson of the nominating and corporate governance committee.
Lci Industries M&A Deal with Patrick Industries, Inc.
LCI Industries announced that its Board of Directors unanimously rejected an unsolicited $101 per share cash acquisition proposal from Monomoy Capital Partners, determining it was not a superior proposal. The company reaffirmed its commitment to its existing merger agreement with Patrick Industries, which is expected to close in the first half of 2027 and generate $150 million in annual cost synergies.